Swiss Lions rankings | 2026 edition
Octapharma
Octapharma is No. 10 in the Pharma and Biotech ranking, with a score of 36.2 out of 100. It is not among the Swiss Lions 100 for 2026. Registered office: Lachen, canton of Schwyz.
- Swiss Lions score
- 36.2
- Swiss Lions 100
- Not in the 100 for 2026
- Pharma and Biotech
- 10of 15
About
Lachen-based, family-owned maker of human proteins from plasma and human cell lines, which describes itself as the world's largest privately owned and independent plasma fractionator.
Octapharma develops and produces human proteins from human plasma and human cell lines for use in medicine. Its products serve three therapeutic areas: haematology, immunotherapy and critical care. The company describes itself as the largest privately owned and independent plasma fractionator in the world, and sources 88% of its plasma from its own donation centres. It has been family-owned since 1983, is headquartered in Lachen in the canton of Schwyz and runs manufacturing sites outside Switzerland, including in Vienna.
- Haematology
- Immunotherapy
- Critical care
- Plasma donation centres
How the score is made
Global scale
CHF 3.4bn revenue.
Swiss value
Swiss headquarters, design and R&D; made abroad.
Global visibility
Online attention across languages, and worldwide search interest.
Impact
No current SBTi target. Not a certified B Corp.
Philanthropy
Family foundation: Octapharma Stiftung.
Impact and philanthropy together make up the impact measure. How the ranking works.
Key figures
- Revenue used in the ranking
- CHF 3.4bn2025, company (EUR 3.64bn)
Not listed on a stock exchange, so profit, dividends and employee numbers are not published in a comparable form.
We have not found a published figure for employees in Switzerland for 2025 or 2026, and dividends paid to Swiss shareholders are not published, so neither is shown.
Profile
- Registered office
- LachenCanton of Schwyz
- Language region
- German-speaking
- Category
- Pharma and Biotech
- Ownership
- Family-ownedMarguerre family
- Charitable foundation
- Octapharma StiftungSet up by the controlling family
- Chief executive
- Wolfgang Marguerre (Chairman and CEO)Source
- Chair
- Wolfgang Marguerre (Chairman and CEO)Source
- Founded
- 1983
In Switzerland
- Lachen SZHeadquarters
Milestones
- 1983Octapharma founded; family-owned since then.
Also in Pharma and Biotech
1RocheScore 77.3
2NovartisScore 75.3
3LonzaScore 56.3
4SandozScore 52.1
5FerringScore 49.8
6SiegfriedScore 44.1
See all 15 brands in Pharma and Biotech. Read the 2026 data story for Pharma and Biotech.
Sources
- Revenue used in the ranking: Octapharma financial review 2025 (2025).
- Company profile, sites, history and milestones: octapharma.com.
- Climate target: Science Based Targets initiative dashboard, status at 30 June 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.
Something out of date?
If a figure is wrong, or Octapharma can publish figures for the next edition, tell us. Corrections are recorded with their source.